NCT03902574View on ClinicalTrials.gov

Bioequivalence Study of Brexpiprazole Orally Disintegrating Tablets (ODT) 2mg

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

March 27, 2019

Primary Completion Date

June 18, 2019

Study Completion Date

June 18, 2019

Conditions
Healthy Adult Male
Interventions
DRUG

Brexpiprazole ODT 2mg with water

Brexpiprazole ODT 2mg is administered with water.

DRUG

Brexpiprazole ODT 2mg without water

Brexpiprazole ODT 2mg is administered without water.

DRUG

Brexpiprazole conventional tablet 2mg

Brexpiprazole conventional tablet 2mg is administered with water.

Trial Locations (1)

Unknown

SOUSEIKAI Hakata clinic, Fukuoka

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY